Rabinowitz Michael
SEC CIK 1876182 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ORMP | ORAMED PHARMACEUTICALS INC. | Chief Commercial Off | 138.0K | — | $167.2K | 2 | 2022-07-28 | 2023-01-03 |
Most active insiders at ORMP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hexter Joshua | COO, CBO | — | $611.4K |
| 2 | Gabay Avraham | CFO | — | $330.7K |
| 3 | Reznick Yehuda | Dir | — | — |
| 4 | Aghion Daniel | Dir | — | — |
| 5 | Shapiro Benjamin | Dir | — | — |
| 6 | Mayer Arie | Dir | — | — |
| 7 | Kidron Miriam | CSO, Dir | — | — |
| 8 | KIDRON NADAV | Pres, CEO, Dir | — | — |
Rabinowitz Michael made no open-market trades at ORMP in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-04 | 2023-01-03 | ORMP | ORAMED PHARMACEUTICALS INC. | Rabinowitz Michael | Chief Commercial Off | S - Sale | $12.55 | -13.3K | 138.0K | -9% | -$167.2K |
| 2022-08-01 | 2022-07-28 | ORMP | ORAMED PHARMACEUTICALS INC. | Rabinowitz Michael | Chief Commercial Off | A - Grant | — | +30.0K | 139.5K | +27% | — |
Purchase Sale Sale after option exercise All abbreviations